Sona Nanotech Inc. (SNANF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.64 Million CAD | -24.1% |
| 2022 | 3.13 Million CAD | -70.78% |
| 2021 | 10.73 Million CAD | 78.59% |
| 2020 | 6 Million CAD | 245.77% |
| 2019 | 1.73 Million CAD | -66.76% |
| 2018 | 5.22 Million CAD | 1361.36% |
| 2017 | 357.72 Thousand CAD | -29.88% |
| 2016 | 510.14 Thousand CAD | -7.65% |
| 2015 | 552.38 Thousand CAD | 10.0% |
| 2014 | 502.17 Thousand CAD | -19.6% |
| 2013 | 624.61 Thousand CAD | -34.56% |
| 2012 | 954.54 Thousand CAD | 9.86% |
| 2011 | 868.84 Thousand CAD | 14.98% |
| 2010 | 755.65 Thousand CAD | -11.29% |
| 2009 | 851.8 Thousand CAD | -69.0% |
| 2008 | 2.74 Million CAD | 108.01% |
| 2007 | 1.32 Million CAD | 417.65% |
| 2006 | 255.19 Thousand CAD | 7102.68% |
| 2005 | 3543.00 CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 561.89 Thousand CAD | -25.45% |
| 2024 Q2 | 595.04 Thousand CAD | 5.9% |
| 2024 Q3 | 711.6 Thousand CAD | 19.59% |
| 2023 FY | 2.38 Million CAD | -24.1% |
| 2023 Q3 | 858.35 Thousand CAD | 70.54% |
| 2023 Q2 | 503.32 Thousand CAD | 34.36% |
| 2023 Q4 | 753.65 Thousand CAD | -12.2% |
| 2023 Q1 | 374.61 Thousand CAD | 156.65% |
| 2022 Q3 | 958.24 Thousand CAD | -27.83% |
| 2022 Q1 | 1.51 Million CAD | -11.09% |
| 2022 Q4 | -661.32 Thousand CAD | -169.01% |
| 2022 Q2 | 1.32 Million CAD | -12.16% |
| 2022 FY | 3.13 Million CAD | -70.78% |
| 2021 FY | 10.73 Million CAD | 78.59% |
| 2021 Q1 | 3.73 Million CAD | 8.12% |
| 2021 Q2 | 3.14 Million CAD | -15.73% |
| 2021 Q3 | 2.15 Million CAD | -31.39% |
| 2021 Q4 | 1.69 Million CAD | -21.19% |
| 2020 Q2 | 528.65 Thousand CAD | 71.91% |
| 2020 Q4 | 3.45 Million CAD | 100.33% |
| 2020 FY | 6 Million CAD | 245.77% |
| 2020 Q1 | 307.52 Thousand CAD | -29.15% |
| 2020 Q3 | 1.72 Million CAD | 225.81% |
| 2019 Q1 | 361.79 Thousand CAD | -92.48% |
| 2019 Q2 | 469.17 Thousand CAD | 29.68% |
| 2019 Q4 | 434.05 Thousand CAD | -6.83% |
| 2019 FY | 1.73 Million CAD | -66.76% |
| 2019 Q3 | 465.85 Thousand CAD | -0.71% |
| 2018 FY | 5.22 Million CAD | 1361.36% |
| 2018 Q4 | 4.8 Million CAD | 3198.71% |
| 2018 Q3 | 145.75 Thousand CAD | -4.5% |
| 2018 Q2 | 152.62 Thousand CAD | 25.93% |
| 2018 Q1 | 121.19 Thousand CAD | 42.21% |
| 2017 Q3 | 88.03 Thousand CAD | 2.93% |
| 2017 FY | 357.72 Thousand CAD | -29.88% |
| 2017 Q4 | 85.22 Thousand CAD | -3.19% |
| 2017 Q2 | 85.52 Thousand CAD | -13.56% |
| 2017 Q1 | 98.94 Thousand CAD | -33.57% |
| 2016 Q2 | 120.54 Thousand CAD | -7.19% |
| 2016 Q4 | 148.95 Thousand CAD | 34.48% |
| 2016 Q3 | 110.76 Thousand CAD | -8.12% |
| 2016 FY | 510.14 Thousand CAD | -7.65% |
| 2016 Q1 | 129.88 Thousand CAD | -6.57% |
| 2015 Q1 | 126.74 Thousand CAD | -17.71% |
| 2015 Q4 | 139.01 Thousand CAD | -3.49% |
| 2015 Q3 | 144.03 Thousand CAD | 1.02% |
| 2015 Q2 | 142.58 Thousand CAD | 12.5% |
| 2015 FY | 552.38 Thousand CAD | 10.0% |
| 2014 Q4 | 154.01 Thousand CAD | 31.01% |
| 2014 Q1 | 122.3 Thousand CAD | -8.94% |
| 2014 Q2 | 108.29 Thousand CAD | -11.46% |
| 2014 Q3 | 117.56 Thousand CAD | 8.56% |
| 2014 FY | 502.17 Thousand CAD | -19.6% |
| 2013 FY | 624.61 Thousand CAD | -34.56% |
| 2013 Q3 | 164.35 Thousand CAD | -1.92% |
| 2013 Q2 | 167.57 Thousand CAD | 5.81% |
| 2013 Q1 | 158.37 Thousand CAD | -15.36% |
| 2013 Q4 | 134.31 Thousand CAD | -18.27% |
| 2012 Q3 | 167.45 Thousand CAD | -54.32% |
| 2012 Q4 | 187.12 Thousand CAD | 11.75% |
| 2012 FY | 954.54 Thousand CAD | 9.86% |
| 2012 Q1 | 294.68 Thousand CAD | 29.26% |
| 2012 Q2 | 366.56 Thousand CAD | 24.39% |
| 2011 Q4 | 227.96 Thousand CAD | 2.68% |
| 2011 Q2 | 212.37 Thousand CAD | 2.85% |
| 2011 Q3 | 222.01 Thousand CAD | 4.54% |
| 2011 FY | 868.84 Thousand CAD | 14.98% |
| 2011 Q1 | 206.48 Thousand CAD | 21.22% |
| 2010 Q1 | 208.13 Thousand CAD | -9.79% |
| 2010 FY | 755.65 Thousand CAD | -11.29% |
| 2010 Q3 | 165.7 Thousand CAD | -21.65% |
| 2010 Q4 | 170.34 Thousand CAD | 2.8% |
| 2010 Q2 | 211.47 Thousand CAD | 1.61% |
| 2009 FY | 851.8 Thousand CAD | -69.0% |
| 2009 Q2 | 223.31 Thousand CAD | -4.21% |
| 2009 Q4 | 230.72 Thousand CAD | 40.14% |
| 2009 Q3 | 164.63 Thousand CAD | -26.28% |
| 2009 Q1 | 233.14 Thousand CAD | -63.45% |
| 2008 Q2 | 1.33 Million CAD | 431.14% |
| 2008 FY | 2.74 Million CAD | 108.01% |
| 2008 Q3 | 524.14 Thousand CAD | -60.73% |
| 2008 Q4 | 637.85 Thousand CAD | 21.69% |
| 2008 Q1 | 251.29 Thousand CAD | -53.08% |
| 2007 FY | 1.32 Million CAD | 417.65% |
| 2007 Q1 | 143.27 Thousand CAD | 30.07% |
| 2007 Q4 | 535.58 Thousand CAD | 60.74% |
| 2007 Q3 | 333.19 Thousand CAD | 7.86% |
| 2007 Q2 | 308.92 Thousand CAD | 115.61% |
| 2006 Q2 | 93.35 Thousand CAD | 217009.3% |
| 2006 Q3 | 52.04 Thousand CAD | -44.25% |
| 2006 Q4 | 110.15 Thousand CAD | 111.66% |
| 2006 FY | 255.19 Thousand CAD | 7102.68% |
| 2006 Q1 | 43.00 CAD | 0.0% |
| 2005 FY | 3543.00 CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -152.449% |
| Arrayit Corporation | 6.19 Million USD | 57.271% |
| Atlantic International Corp. | 5.57 Million USD | 52.527% |
| Biocept, Inc. | 29.4 Million USD | 90.993% |
| Bioqual, Inc. | 7.44 Million USD | 64.448% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -242.967% |
| DermTech, Inc. | 104.01 Million USD | 97.454% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 98.41% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 88.295% |
| iMD Companies, Inc. | 151.8 Thousand USD | -1644.424% |
| IDenta Corp. | 662.97 Thousand USD | -299.441% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 86.911% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -6711.021% |
| InVitro International | 661.32 Thousand USD | -300.438% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | 62.691% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -4457.05% |
| Medical Imaging Corp. | 1.91 Million USD | -38.492% |
| NovelStem International Corp. | 3.53 Million USD | 25.146% |
| Optigenex Inc. | 1.28 Million USD | -105.626% |
| PharmChem, Inc. | 2.93 Million USD | 9.656% |
| Proteome Sciences plc | 3.26 Million USD | 18.966% |
| Response Genetics, Inc | 25.31 Million USD | 89.541% |
| Rennova Health, Inc. | 7.67 Million USD | 65.508% |
| RushNet, Inc. | 1.78 Million USD | -48.0% |
| ScreenPro Security Inc. | 3.23 Million USD | 18.238% |
| Stella Diagnostics Inc. | 11.42 Million USD | 76.825% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | 63.936% |
| Todos Medical Ltd. | 14.05 Million USD | 81.162% |